Bank of New York Mellon’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-169,284
| Closed | -$874K | – | 4296 |
|
|
2019
Q2 | $874K | Buy |
169,284
+2,829
| +2% | +$14.6K | ﹤0.01% | 3308 |
|
|
2019
Q1 | $599K | Buy |
166,455
+2,273
| +1% | +$8.18K | ﹤0.01% | 3463 |
|
|
2018
Q4 | $1.01M | Buy |
164,182
+16,270
| +11% | +$99.7K | ﹤0.01% | 3093 |
|
|
2018
Q3 | $864K | Sell |
147,912
-705
| -0.5% | -$4.12K | ﹤0.01% | 3354 |
|
|
2018
Q2 | $632K | Buy |
148,617
+3,180
| +2% | +$13.5K | ﹤0.01% | 3509 |
|
|
2018
Q1 | $641K | Buy |
145,437
+879
| +0.6% | +$3.87K | ﹤0.01% | 3449 |
|
|
2017
Q4 | $760K | Buy |
144,558
+5,496
| +4% | +$28.9K | ﹤0.01% | 3397 |
|
|
2017
Q3 | $853K | Buy |
139,062
+1,960
| +1% | +$12K | ﹤0.01% | 3312 |
|
|
2017
Q2 | $992K | Buy |
137,102
+11,229
| +9% | +$81.2K | ﹤0.01% | 3258 |
|
|
2017
Q1 | $667K | Sell |
125,873
-3,786
| -3% | -$20.1K | ﹤0.01% | 3437 |
|
|
2016
Q4 | $931K | Sell |
129,659
-7,642
| -6% | -$54.9K | ﹤0.01% | 3298 |
|
|
2016
Q3 | $1.29M | Buy |
137,301
+437
| +0.3% | +$4.09K | ﹤0.01% | 3040 |
|
|
2016
Q2 | $866K | Buy |
136,864
+19,590
| +17% | +$124K | ﹤0.01% | 3242 |
|
|
2016
Q1 | $647K | Sell |
117,274
-12,818
| -10% | -$70.7K | ﹤0.01% | 3311 |
|
|
2015
Q4 | $726K | Sell |
130,092
-24,525
| -16% | -$137K | ﹤0.01% | 3345 |
|
|
2015
Q3 | $1.31M | Sell |
154,617
-9,976
| -6% | -$84.4K | ﹤0.01% | 2998 |
|
|
2015
Q2 | $2.49M | Sell |
164,593
-33,899
| -17% | -$512K | ﹤0.01% | 2766 |
|
|
2015
Q1 | $3.18M | Buy |
198,492
+2,482
| +1% | +$39.7K | ﹤0.01% | 2570 |
|
|
2014
Q4 | $3.49M | Buy |
196,010
+63,421
| +48% | +$1.13M | ﹤0.01% | 2506 |
|
|
2014
Q3 | $1.33M | Sell |
132,589
-2,806
| -2% | -$28.2K | ﹤0.01% | 3130 |
|
|
2014
Q2 | $2.11M | Buy |
135,395
+53,566
| +65% | +$836K | ﹤0.01% | 2876 |
|
|
2014
Q1 | $1.52M | Buy |
81,829
+50,995
| +165% | +$947K | ﹤0.01% | 3060 |
|
|
2013
Q4 | $589K | Buy |
30,834
+17,167
| +126% | +$328K | ﹤0.01% | 3507 |
|
|
2013
Q3 | $224K | Buy |
+13,667
| New | +$224K | ﹤0.01% | 3740 |
|